Check 35,000+ stocks against 26 valuation models and 37 quality factors

Health and Happiness (H&H) International Holdings Ltd (1112) fair value: what the stock is really worth

As of Sep 29, 2026: fair value of Health and Happiness (H&H) International Holdings Ltd HK$25.62, price HK$18.70, upside +37.0%, quality 62 out of 100. Calculated from audited financials with 26 valuation models and 37 quality factors, updated daily.

Fair value above price? Yes
Good quality? Yes
Add to watchlist

Consumer Defensive · HK · ISIN KYG4387E1070

HA Broad data Sep 27, 2026

Health and Happiness (H&H) International Holdings Ltd

1112 · HK

UndervaluedThe stock appears undervalued with acceptable quality.

✓Fair value HK$25.62 · Undervalued (+37.0%)

✓Quality 62/100

!Mixed Growth (revenue 5y +5.1 %/yr)

!Thin margins · 1.4% net margin (TTM)

✓Moderate debt · generates free cash flow

✓1.7% dividend yield · Well covered

!Mixed vs. peers (7/13)

!Narrow moat 34/100

!Weak on past: 13 out of 100

26 models, one by oneBear HK$13.82 to bull HK$37.31 Growth analysisrevenue history, year by year Quality 62/100 in detail37 factors, each one shown Compared with its peersrank on every measure, side by side

Watch Health and Happiness (H&H) International Holdings Ltd for free, get notified when fair value or trend changes. Plus fair value for all 35,000+ stocks, 14 days of Pro free, no card. Watch for free Pro now: $1 first month

What runs behind every stock

26 valuation models 8 families, DCF to NCAV 37 quality factors margins, balance sheet, cashflow, debt 6 AI factors moat, what no ratio measures 2,000+ data points verified, per stock, median

69 individual criteria per stock, every one traceable See the method →

Price vs Fair Value

White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Sep 27, 2026.

How to read this chart

60‑month range HK$5.75 – HK$26.08 · fair‑value band HK$13.82 – HK$37.31 · the HK$18.70 price screens below the HK$25.62 fair value. Dashed = 300-day average. As of Sep 27, 2026.

Follow Health and Happiness (H&H) International Holdings in your weekly email

Every Wednesday you see whether Health and Happiness (H&H) International Holdings is on track or worth a review, plus price against fair value. Free, up to 3 stocks.

We send you a confirmation link. Unsubscribe with one click.

Which stocks are undervalued right now? Check free Discover now →

Company profile

Health and Happiness (H&H) International Holdings Limited, an investment holding company, manufactures and sells pediatric nutrition, baby care, adult nutrition and care, and pet nutrition and care products in Mainland China, Australia, New Zealand, North America, and internationally. The company offers milk formulas for infants, children, and expectant and nursing mothers; probiotic and nutrition supplements in the form of sachets, capsules, gummies, and tablets for infants, children, and expectant mothers; and vitamins, herbal and mineral supplements, and skin care and sports nutrition products for adults; dried baby food and baby care products; and complete pet food products and multicondition pet supplements. In addition, it is involved in the research, development, manufacture, sale, and processing of meat, fruit, vegetable powder, candy, special nutritional food, and nutritional products; marketing and distribution of organic baby food; wholesale, retail, import, and export of nutritional food and personal care products for infants; and provision of packaging services. Further, the company engages in the trading and sale of vitamins, health supplements, and skin care and sports nutrition products for adults; and pet food, and nutritional supplements for pets, as well as the online sale and provision of software and information technology. It provides its products under the Healthy Times, Farmland, Swisse, Aurelia, Zesty Paws, Solid Gold, Dodie, and Good Goût brand names. The company was formerly known as Biostime International Holdings Limited and changed its name to Health and Happiness (H&H) International Holdings Limited in June 2017. The company was founded in 1999 and is headquartered in Quarry Bay, Hong Kong. Health and Happiness (H&H) International Holdings Limited is a subsidiary of Coliving Holdings Limited.

Stock analysis

Health and Happiness (H&H) International Holdings Ltd (1112) currently trades at HK$18.70, while our model-based Fair Value estimate is HK$25.62, implying the stock looks roughly 27.0% undervalued today.

Valuation

Bull case: the Growth DCF group reads highest at a median of HK$36.02 per share, and 11 of the 24 models we run sit above the HK$18.70 price.

Bear case: the Earnings-Based group reads lowest at HK$4.72, and 13 of the 24 models stay below the price. Evidence for this calculation is high.

Scenario range: HK$13.82 (bear) to HK$37.31 (bull), the price of HK$18.70 sits inside it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.

Quality & growth

The Quality Score stands at 62/100 (solid quality), in the Consumer Defensive sector.

Mixed Growth: Revenue is growing, but margins or cash flow do not fully confirm the trend.

Health and Happiness (H&H) International Holdings Ltd reported revenue of 14.4B CNY in FY2025 versus 11.5B CNY in FY2021, a compound +5.6%/yr. Reported net income was 196M CNY in FY2025, compounding −21.2%/yr from FY2021.

Key figures

Market cap HK$12.0B (≈ $1.5B) · P/E ratio 52.3 · P/S ratio 0.71 · EPS (TTM) HK$0.3575 · Dividend yield 1.7% · Net margin 1.4% · Return on equity 3.3% · Return on assets (EBIT) 8.2%.

Competitive moat

Our AI-assisted moat analysis scores the competitive advantage at 42 out of 100 (low confidence).

What moves the price

The last reported earnings sit well below what analysts expect (earnings in transition, for example after write-downs or an earnings dip); whether the stock is cheap or expensive hinges on the expected recovery actually arriving. Read the fair value with that caveat.

The share trades about 2% below its 52-week high and 84% above its 52-week low, currently above its 200-day average.

For context, the median of 10 Consumer Defensive peers we cover trades at 3% fair-value upside, at 37%, 1112 screens cheaper than that median.

Fair Value models

Bear HK$13.82 Fair Value HK$25.62 Bull HK$37.31

Model ⓘEach model values the company its own way (discounted cash flow, earnings, assets, dividends). The fair value above is their evidence-weighted blend, not the output of a single model. Bear ⓘBear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull ⓘBull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target. If a model's bull case is above four times its base value, the table shows that limit with a > sign (like the overall Bull above): beyond it no assumption holds. Evidence ⓘEvidence = how well-backed THIS model's estimate is for this stock (0–100): how complete and reliable its input data are, and how well the model fits the company. The final Fair Value is an evidence-weighted blend, so better-evidenced models count more. Green ≥70, amber 50–69, grey below 50.

Highest evidence

FCF DCF HK$18.24 HK$39.68 HK$73.65 76

Residual Income HK$7.45 HK$7.09 HK$7.09 76

Growth DCF HK$17.61 HK$36.02 HK$63.17 75

All 24 models by family

DCF Models

FCF DCF HK$18.24 HK$39.68 HK$73.65 76

Owner Earnings HK$8.44 HK$22.72 HK$45.33 71

5Y Revenue Exit HK$16.68 HK$37.84 HK$66.87 69

5Y EBITDA Exit HK$19.95 HK$44.75 HK$76.28 72

5Y P/E Exit HK$2.84 HK$8.63 HK$14.82 67

10Y Revenue Exit HK$16.06 HK$35.44 HK$65.73 63

10Y EBITDA Exit HK$18.87 HK$40.13 HK$73.09 65

10Y P/E Exit HK$8.39 HK$15.61 HK$24.99 62

Earnings-Based

Graham-Dodd HK$2.42 HK$12.19 HK$16.83 64

Lynch FV HK$3.31 HK$4.72 HK$6.14 61

PEG = 1.0 HK$3.31 HK$4.72 HK$6.14 57

EPV HK$7.78 HK$10.36 HK$12.50 74

Multiples

P/E Multiple HK$5.60 HK$7.46 HK$9.33 63

P/S Multiple HK$4.53 HK$6.04 HK$7.55 58

P/B Multiple HK$4.53 HK$6.04 HK$7.55 55

EV/EBIT HK$27.47 HK$40.33 HK$53.19 65

EV/EBITDA HK$23.75 HK$35.37 HK$46.99 66

EV/Revenue HK$16.21 HK$27.91 HK$39.61 52

Asset-Based

NCAV (Graham) HK$5.43 HK$7.28 HK$10.86 54

Growth DCF

Growth DCF HK$17.61 HK$36.02 HK$63.17 75

Rev-Margin DCF HK$16.68 HK$37.27 HK$64.59 69

Economic Profit

Residual Income HK$7.45 HK$7.09 HK$7.09 76

ROIC Compounder HK$7.78 HK$10.36 HK$14.62 71

Growth Earnings

Growth-Adj P/E HK$5.03 HK$7.18 HK$9.33 67

Open the full fair value analysis →

Notify me when 1112 reaches fair value

Put 1112 on your watchlist. We get in touch as soon as price and fair value meet or the trend turns.

Set up alert →

Quality Score breakdown

Overall quality 62/100

Of which business quality 59 · Market factors (momentum, volatility) 72

Profitability 40

Margins and returns on capital today

Quality Growth 65

Are margins and returns improving?

Cashflow 68

Earnings quality: real cash, not paper profit

Fin. Strength 29

Balance sheet, leverage, solvency risk

Investment 100

Disciplined investing over empire-building

Low Volatility 37

Calm price path (market factor)

Momentum 89

Price trend over the last 3–12 months (market factor)

52W Momentum 82

Distance to the 52-week high (market factor)

Net Issuance 82

Share count: buybacks or dilution?

Open the full quality analysis →

Revenue & earnings trend

Growth Quality ⓘGrowth is valuable only when reinvestment earns attractive returns (Aswath Damodaran): sustainable growth depends on return on capital, reinvestment and efficiency. Basis: total company revenue over the periods shown on the cards (3Y/5Y/all years), not per share, so a merger can show up as a growth jump; per-share earnings growth is in the value-creation card. 64/100

Revenue is growing, but margins or cash flow do not fully confirm the trend.

Revenue growth 1 year

+10.0%

Revenue growth 3 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.

+4.0%

Revenue growth 5 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.

+5.1%

Start year 2020 (pandemic). Over 10 years: +11.5% a year

Revenue growth 18 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.

+27.2%

’14

’15

’16

’17

’18

’19

’20

’21

’22

’23

’24

’25

What shareholders gained per year (last 5 years) ⓘWhat the business itself delivers per year: earnings growth per share plus the dividend yield. This is what you get IF the market keeps valuing the stock the same way: it contains no assumption about the market changing its mind. Computed per share, so buybacks count and a merger does not pass as growth. For a company that pays no dividend it is pure earnings growth per share. Period: earnings growth per share as CAGR over the last 5 reported fiscal years (annual statements), plus the current dividend yield. The start value is the median of the three years around the start, so a single crisis year (a pandemic or a write-down) does not distort the rate. Basis: EBIT basis.

+0.5%

Earnings growth per share plus dividend.

Earnings per share, growth per year−1.2%

Dividend (yield on the price)1.7%

Pace: 5 vs 10 years ⓘTwo data points, not a trend model: earnings growth per share over the last 5 fiscal years against the last 10. Labelled "steady" when both rates are within 3 percentage points of each other, otherwise picking up or flattening. Shown only when ten years of history exist.−27.8% vs −13.6%, slowing

Profit margin 2020 to 2025 ⓘOperating margin then vs now, from reported annual statements. A falling margin after a boom year is the classic peak-earnings signal: the growth rate then leans on an inflated base.16% → 12%

Start year 2020 (pandemic)

Growth Forecast

A lot of optimism in the price

The price assumes more growth than the company has delivered so far and more than analysts expect.

What the price assumes ⓘThis turns our valuation around: instead of asking what the share is worth, it asks what growth the current price requires. It uses the cash the company keeps after all spending (free cash flow), the same discount rate as our models, five years of growth, then slowing evenly to 2 % a year by year ten. Compared with the analysts' sales forecasts extended to the same five years (at least three analysts, for context only, it does not enter the Fair Value): within 3 percentage points counts as "in line" (amber), below that little optimism (green), above that a lot of optimism (red).

+14.7%

Yearly growth needed for the next five years to justify today's price.

What forecasts expect ⓘAnalysts publish sales forecasts for the next two fiscal years. For the years after that, growth slows evenly to 2 % a year by year ten (2 % is the long-run rate our models use). Projected years are marked as such.

+8.2%

Yearly sales growth analysts expect, extended to five years.

After inflation (figures in CNY, China: IMF forecast 1.7% a year to 2030, 1.4% from 2016 to 2025) that is about +12.8% a year for the price and +6.4% for the forecasts.

Forecast 2026 (sales)+10.1%

Forecast 2027 (sales)+9.0%

Projected 2028 (sales)+8.2%

Projected 2029 (sales)+7.3%

Projected 2030 (sales)+6.4%

Watch 1112, get fair value alerts →

Compare Health and Happiness (H&H) International Holdings Ltd with another stock

Price, fair value, quality and upside side by side.

First stock

Second stock

Free, no sign-up

Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Packaged Foods · 646 stocks

Beats the industry median on 7/13 measures

A mixed picture versus its industry peers.

Valuation

Quality Score 62 · Above median

Fair Value upside +37.0% · Above median

Profitability

Return on equity (TTM) 3.3% · Below median

Return on assets 5.1% · Above median

Net margin (TTM) 1.4% · Below median

Operating margin (TTM) 8.8% · Above median

Growth and dividend

Revenue growth 15.3% · Top 25%

Dividend yield (TTM) 1.7% · Below median

Balance sheet

Debt / equity 1.30× · Highest 25%

Valuation Multiplesvs Packaged Foods median · lower = cheaper

P/E (TTM) 52.3× · Priciest 25%

P/B 1.71× · book value is mostly goodwill ⓘGoodwill and other intangible assets are larger than the equity. The book value mainly reflects prices paid for past acquisitions, so we do not rank this P/B against the peer group.

P/S (TTM) 0.71× · Cheaper than median

P/FCF 10.8× · Cheaper than median

EV/EBITDA 9.2× · Pricier than median

Strength profile in five axes (Snowflake)

This stock

Sector peers

VALUE (fair-value potential)83 · sector 33

FUTURE (revenue growth)77 · sector 19

PAST (return on equity)13 · sector 30

HEALTH (low debt)35 · sector 96

DIVIDEND (yield)34 · sector 57

Context: sector, industry, market

Values & ESG

Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.

None of the checked exposures detected

Similar stocks

10 more Packaged Foods stocks, each showing price versus our Fair Value estimate.

Stock	Price	Fair Value	vs Fair Value
Nestlé S.A NESN	CHF 77.17	CHF 59.51	−23%
Danone S.A BN	€59.56	€50.65	−15%
Foshan Haitian Flavouring and Food Company 603288	¥33.93	¥37.32	+10%
The Kraft Heinz Company KHC	$23.63	$29.20	+24%
Nestlé India Limited NESTLEIND	₹1,363	₹724.74	−47%
Inner Mongolia Yili Industrial Group 600887	¥26.90	¥41.84	+56%
Yihai Kerry Arawana Holdings 300999	¥24.55	¥9.98	−59%
General Mills, Inc GIS	$33.64	$34.59	+3%
Wilmar International Limited F34	3.68 SGD	5.14 SGD	+40%
Kerry Group KRZ	€85.55	€59.96	−30%

Explore undervalued stocks

More undervalued Consumer Defensive stocks →

All undervalued stocks Technology Financial Services Healthcare Consumer Cyclical Consumer Defensive Communication Services Industrials Energy Basic Materials Real Estate Utilities Deeply Undervalued Stocks Undervalued High-Quality Stocks Undervalued Blue-Chip Stocks Undervalued Small-Cap Stocks Undervalued Dividend Stocks

Try a ready-made strategy

Pick a strategy and jump into the live analysis with that exact screen applied.

🥇 Backtested Best 🏆 Big Names ⭐ Top Rated 💎 Quality on Sale 🚀 Profitable Growth 🧊 Quality Compounders 💵 Dividend Stars 📈 Strong Momentum 📉 Fallen Angels ⚖️ Deeply Undervalued 🔍 Small-Cap Gems 🏰 Moat at a Fair Price 💼 Insider Buying 🎩 Buffett-Style Quality 📚 Peter Lynch GARP 🧮 Greenblatt Magic Formula 🛡️ Graham Defensive

Discover tools

Stock screenerFilter by region, size and sector Compare toolTwo stocks side by side Extrinsic Value Calculator…Calculator with industry benchmark Peter Lynch Fair Value Formula &…Calculator with industry benchmark

Run the numbers yourself: free valuation calculators

DCF Calculator Graham Number Peter Lynch Formula DDM Calculator Fama-French Model Intrinsic Value

For bloggers & editors: embed code + live data

For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.

Health and Happiness (H&H) International Holdings Ltd · Fair Value
HK$25.62 +27%Fair Value
Calculator →

<a href="https://www.fairvalue-calculator.com/stock/1112" target="_blank" rel="nofollow noopener" style="display:inline-flex;align-items:center;gap:12px;box-sizing:border-box;font-family:system-ui,-apple-system,Segoe UI,Roboto,sans-serif;text-decoration:none;background:#0f1814;color:#eaf2ed;border:1px solid #2a3a30;border-radius:12px;padding:12px 16px;max-width:360px"><span style="line-height:1.35"><span style="font-size:12px;color:#9fb0a8">Health and Happiness (H&amp;H) International Holdings Ltd · Fair Value</span><br><b style="font-size:20px">HK$25.62</b> <span style="color:var(--fvc-g-mitte);font-weight:700;font-size:14px">+27%</span></span><span style="font-size:11px;color:var(--fvc-g-mitte);font-weight:700;margin-left:auto;text-align:right;line-height:1.3">Fair&nbsp;Value<br>Calculator&nbsp;→</span></a>

Cite: Fair Value Calculator (2026). "Health and Happiness (H&H) International Holdings Ltd Fair Value". https://www.fairvalue-calculator.com/stock/1112

Frequently asked questions

Is Health and Happiness (H&H) International Holdings Ltd (1112) overvalued or undervalued?

As of Sep 27, 2026, our model estimates a fair value of HK$25.62 versus a price of HK$18.70, about +37% upside (undervalued).

What is the fair value of 1112?

Our model-based fair value for Health and Happiness (H&H) International Holdings Ltd is HK$25.62 (as of Sep 27, 2026), built from audited fundamentals. The current price: HK$18.70.

What is the quality score of 1112?

Health and Happiness (H&H) International Holdings Ltd has a Quality Score of 62/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.

What is the price target for Health and Happiness (H&H) International Holdings Ltd (1112)?

Our model-based price target is the fair value of HK$25.62 (as of Sep 27, 2026) from 24 valuation models. Cautious scenario HK$13.82, optimistic scenario HK$37.31. It is a calculation from audited fundamentals, not an analyst target.

What is the Health and Happiness (H&H) International Holdings Ltd stock forecast for 2026?

Our models put fair value at HK$25.62, about +37% upside versus a price of HK$18.70 (undervalued). Cautious scenario HK$13.82, optimistic scenario HK$37.31. The calculation is refreshed regularly with new filings.

What is the revenue of Health and Happiness (H&H) International Holdings Ltd (1112)?

Health and Happiness (H&H) International Holdings Ltd reported trailing-twelve-month revenue of about 14.4B CNY (latest available figure, as of Sep 27, 2026).

Does Health and Happiness (H&H) International Holdings Ltd pay a dividend?

Health and Happiness (H&H) International Holdings Ltd currently shows a dividend yield of about 1.68% relative to its recent price (as of Sep 27, 2026).

What growth is priced into Health and Happiness (H&H) International Holdings Ltd (1112)?

For today's price to be fair in a discounted-cash-flow model, Health and Happiness (H&H) International Holdings Ltd would have to grow free cash flow by +14.7 % per year for five years (discount rate 12.6 %, then slowing evenly to 2 % perpetual growth by year ten). Over the last 5 years revenue grew +5.1 % per year. As of Sep 27, 2026.

What discount rate (WACC) does the fair value of 1112 use?

Our models discount Health and Happiness (H&H) International Holdings Ltd at 12.6 %: a base by market capitalisation (small), damped by beta 1.28, country premium for Hong Kong. The same rate applies in all 26 models.

What is a reverse DCF?

A reverse DCF turns the usual calculation around. Instead of deriving a value from assumptions, it takes today's price as given and asks: what free-cash-flow growth would a company have to deliver for exactly this price to be fair? The result is not a forecast but the expectation already priced in. For Health and Happiness (H&H) International Holdings Ltd that is +14.7 % per year a year over ten years, using the same discount rate (12.6 %) and the same formula as our fair value.

How much growth has Health and Happiness (H&H) International Holdings Ltd (1112) delivered so far?

Over the past 5 years revenue at Health and Happiness (H&H) International Holdings Ltd grew +5.1 % a year. The price currently implies +14.7 % per year free-cash-flow growth a year. Comparing the two shows how much confidence is in the price: if it demands more than has been delivered, the business has to accelerate for the maths to work.

How fast is the sector of Health and Happiness (H&H) International Holdings Ltd (1112) growing?

The median revenue growth in the sector is +2.9 % a year. That is the yardstick for the growth priced into Health and Happiness (H&H) International Holdings Ltd (+14.7 % per year a year): it shows whether the expectation is within the usual range or beyond it.

What is the free cash flow yield of Health and Happiness (H&H) International Holdings Ltd (1112)?

The free-cash-flow yield on the price is 9.23 %: that much free cash flow Health and Happiness (H&H) International Holdings Ltd produces per unit of market value. When it exceeds the discount rate of our models (12.6 %), the business already earns more than its cost of capital demands, and the price needs little additional growth.

What is the intrinsic value of Health and Happiness (H&H) International Holdings Ltd (1112)?

Intrinsic value and fair value mean the same thing: what the business is worth on its numbers, independent of the share price. For Health and Happiness (H&H) International Holdings Ltd it is HK$25.62 per share (as of Sep 27, 2026), against a price of HK$18.70. It is the blended result of 24 valuation models (cash flow, earnings, asset, dividend).

Is Health and Happiness (H&H) International Holdings Ltd stock overvalued or undervalued in 2026?

As of Sep 27, 2026, 1112 trades below its calculated fair value: price HK$18.70, fair value HK$25.62, a gap of about +37% (undervalued). The calculation is refreshed with each new quarterly report, so the verdict can change during the year.

Is fair value the same as the market price of 1112?

No. The price is what the market pays today (HK$18.70); the fair value is what the company's own numbers justify (HK$25.62). For Health and Happiness (H&H) International Holdings Ltd the two are HK$6.92 per share apart. That gap is exactly why we show both numbers side by side.

How much is Health and Happiness (H&H) International Holdings Ltd worth?

The market values Health and Happiness (H&H) International Holdings Ltd at about HK$12.0B (market capitalisation, as of Sep 27, 2026). Per share that is HK$18.70; our models calculate a fair value of HK$25.62 per share.

What do the bullish and bearish scenarios say about 1112?

Our models span a range for Health and Happiness (H&H) International Holdings Ltd: cautious scenario HK$13.82, base HK$25.62, optimistic HK$37.31 per share (as of Sep 27, 2026, price HK$18.70). The range comes from different growth and margin assumptions, not from analyst opinions.

What is the P/E ratio of 1112?

Health and Happiness (H&H) International Holdings Ltd trades at a price-to-earnings ratio of 52.3 (as of Sep 27, 2026). A P/E on its own says little: it compares the price with ONE year of profit, while our fair value of HK$25.62 is built from several models across several years. Excluding one-off items of fiscal year 2025 it is 15.2 (reported 52.3). Other multiples: P/B 1.7, P/S 0.7, EV/EBITDA 9.2.

How solid is the balance sheet of Health and Happiness (H&H) International Holdings Ltd (1112)?

Balance-sheet figures for Health and Happiness (H&H) International Holdings Ltd (as of Sep 27, 2026): return on equity 3.3%, debt of 1.30 per unit of equity. They feed the Quality Score of 62/100, which measures business quality independently of the share price.

How far is 1112 from its 52-week high?

Health and Happiness (H&H) International Holdings Ltd trades at HK$18.70, about 2% below its 52-week high of HK$19.04 and 84% above the low of HK$10.18 (as of Sep 29, 2026). Distance from the high says nothing about value: that is what the fair value of HK$25.62 is for.

Which stocks are comparable to Health and Happiness (H&H) International Holdings Ltd?

From the same area (Consumer Defensive) we also value Nestlé S.A, Danone S.A, Foshan Haitian Flavouring and Food Company, The Kraft Heinz Company, among others. Each of them has its own fair-value calculation on this site using the same models, so the comparison is like for like.

Is Health and Happiness (H&H) International Holdings Ltd stock attractive at the current price?

The data as of Sep 27, 2026: price HK$18.70, calculated fair value HK$25.62 (+37%), Quality Score 62/100, from 24 models. Whether that fits your horizon and risk tolerance is your call. We provide the calculation, not investment advice.

How is the fair value of 1112 calculated?

We run Health and Happiness (H&H) International Holdings Ltd through 24 models from four families: discounted cash flow, earnings models, asset and balance-sheet models, and dividend models. Every model gets the same audited fundamentals; the result is the weighted average of HK$25.62, with the spread shown as a cautious and an optimistic scenario.

Is it still worth investing in stocks now?

The global stock market currently sits 14.9 % above its aggregate fair value. Health and Happiness (H&H) International Holdings Ltd currently trades 27 % below its own fair value, and the market average says nothing about that. An expensive market is no reason to stay out and no reason to buy everything at once: keep a broad savings plan running, buy single stocks only with money you can do without, and hold part of your money liquid while the market is high. The full picture including sectors is on is it worth investing now.

What is the share price of Health and Happiness (H&H) International Holdings Ltd (1112)?

The closing price on Sep 29, 2026 was HK$18.70. Our model-based fair value is HK$25.62, about +37% upside (undervalued). We carry closing prices from our data provider, not a live tick.

What should I pay attention to with Health and Happiness (H&H) International Holdings Ltd right now?

The model range is unusually wide (HK$13.82 to HK$37.31). The outcome hinges heavily on assumptions, so read the point estimate with caution. Solid quality (62/100) at a price below fair value, the discount is the argument here, not the business quality.

Where does the earnings growth of Health and Happiness (H&H) International Holdings Ltd (1112) come from?

Earnings per share at Health and Happiness (H&H) International Holdings Ltd grew −6.2 % a year from 2014 to 2025. Broken into its drivers: revenue per share +11.0 %, EBIT margin −6.3 %, tax rate −3.0 %, residual (interest, one-offs) −7.1 %. The four rates multiply to the earnings growth rate, they do not add up. Start and end are three-year averages so a single exceptional year does not distort the result.

Key figures of Health and Happiness (H&H) International Holdings Ltd

How large is the market capitalisation of Health and Happiness (H&H) International Holdings Ltd (1112)?

The market capitalisation of Health and Happiness (H&H) International Holdings Ltd is HK$12.0B (≈ $1.5B). The stock-market value of the whole company: share price times number of shares. It is what the market asks for the entire business today.

What is the P/S ratio of Health and Happiness (H&H) International Holdings Ltd (1112)?

The price-to-sales ratio of Health and Happiness (H&H) International Holdings Ltd is 0.71 (P/E × margin). Price to sales: market value relative to yearly revenue. Useful when profit is thin or distorted.

What are the earnings per share of Health and Happiness (H&H) International Holdings Ltd (1112)?

Earnings per share at Health and Happiness (H&H) International Holdings Ltd are HK$0.3575 (price ÷ EPS = P/E 52.3). Earnings per share over the last twelve months: total profit spread across every single share.

What is the dividend yield of Health and Happiness (H&H) International Holdings Ltd (1112)?

The dividend yield of Health and Happiness (H&H) International Holdings Ltd is 1.7% (payout 25.8%, on adjusted earnings, reported 88.5%). Yearly dividend relative to the share price. 3% pays 3 per 100 invested. Below: how much of profit is used for it.

What is the net margin of Health and Happiness (H&H) International Holdings Ltd (1112)?

The net margin of Health and Happiness (H&H) International Holdings Ltd is 1.4% (fiscal year 2025). How much of every unit of revenue ends up as profit. 10% means 10 cents of profit per dollar of sales.

What is the return on equity of Health and Happiness (H&H) International Holdings Ltd (1112)?

The return on equity (ROE) of Health and Happiness (H&H) International Holdings Ltd is 3.3% (last twelve months). Profit relative to shareholders' equity, how efficiently the company works with its owners' money.

What is the EBIT return on assets of Health and Happiness (H&H) International Holdings Ltd (1112)?

On an EBIT basis the return on assets of Health and Happiness (H&H) International Holdings Ltd is 8.2% (avg 5y). Operating profit (EBIT) relative to everything the company owns, as a multi-year average. It describes the business model rather than one good or bad year.

What is the operating margin of Health and Happiness (H&H) International Holdings Ltd (1112)?

The operating margin of Health and Happiness (H&H) International Holdings Ltd is 8.8% (last twelve months). Profit from the core business (before interest and taxes) relative to revenue.

How fast is revenue growing at Health and Happiness (H&H) International Holdings Ltd (1112)?

Revenue at Health and Happiness (H&H) International Holdings Ltd is growing +15.3% versus a year earlier (3y avg +4.0%). How much revenue grew versus a year earlier (YoY). The 3-year average next to it puts the single year in context.

How fast are earnings growing at Health and Happiness (H&H) International Holdings Ltd (1112)?

Earnings per share at Health and Happiness (H&H) International Holdings Ltd are growing −76.9% versus a year earlier. How much earnings per share grew versus a year earlier.

How much net debt does Health and Happiness (H&H) International Holdings Ltd (1112) carry?

The net debt of Health and Happiness (H&H) International Holdings Ltd is 7.4B CNY (fiscal year 2025, ≈ 7.8 yrs of FCF). Debt minus cash on hand. The note shows how many years of free cash flow could in theory pay it off.

Free · no account needed

Watch Health and Happiness (H&H) International Holdings Ltd in the live analysis

One click puts Health and Happiness (H&H) International Holdings Ltd on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 35,000+ stock screener. You can also try 14 days of Pro there, no card.

Watch for free →

Zero risk: nothing is ever charged. Your watchlist is yours, with or without an account.